The probiotic mixture VSL#3 dampens LPS-induced chemokine expression in human dendritic cells by inhibition of STAT-1 phosphorylation.
VSL#3, a mixture of 8 different probiotic bacteria, has successfully been used in the clinic to treat Ulcerative Colitis. We previously identified the modulation of chemokines as a major mechanism in the protective effect of the VSL#3 in a mouse model of colitis. This was supported by in vitro studi...
Main Authors: | Rob Mariman, Frans Tielen, Frits Koning, Lex Nagelkerken |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4278714?pdf=render |
Similar Items
-
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial
by: Giuseppe Derosa, et al.
Published: (2022-05-01) -
Correction: Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3.
by: François P Douillard, et al.
Published: (2018-01-01) -
The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor.
by: Poonam Dharmani, et al.
Published: (2013-01-01) -
Correction: The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor.
by: Poonam Dharmani, et al.
Published: (2022-01-01) -
Correction: The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor
Published: (2022-01-01)